Latest Capital Inflows News

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Antipa Minerals reports robust progress at its Minyari Dome Gold-Copper Project, highlighted by a positive Scoping Study and promising Phase 2 drilling results, alongside a strengthened cash position of A$36.5 million following a strategic equity raise and asset sale.

Calix Limited has extended its Share Purchase Plan closing date to January 31, 2025, offering eligible shareholders more time to invest up to $30,000 each. The company may close the plan early if subscriptions exceed $5 million, signaling strong investor interest in its decarbonisation technology.